Analyzing the Future of Veterinary Intravenous (IV) Solutions Market Dynamics 2025-2034: Growth Rate, Trends, and Major Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
What key factors are powering the surge in the veterinary intravenous (iv) solutions market right now?
Over recent years, there has been a significant expansion in the market size for veterinary intravenous (IV) solutions. The market, which was valued at $1.5 billion in 2024, is forecasted to reach $1.62 billion in 2025, showing a compound annual growth rate (CAGR) of 8.1%. The previous period’s growth is due to factors such as the surge in the number of veterinary clinics and the rising incidences of dehydration. Further contributing factors include the expansion of livestock farming, the growing number of companion animals, and advancements in veterinary diagnostics.
How fast Is the veterinary intravenous (iv) solutions market expected to grow, and what’s its future value?
The market size for veterinary intravenous (IV) solutions is predicted to experience substantial expansion in the upcoming years. The expectations are that it will surge to $2.19 billion by 2029, with a compound annual growth rate (CAGR) of 7.8%. This projected growth can be tied to a surge in pet insurance adoption, increased spending on animal healthcare, enhanced awareness about animal health, escalating prevalence of animal diseases, and wider pet insurance coverage. Key trends during this forecasted period are expected to include technological progression, assorted product formulations, the incorporation of telemedicine, state-of-the-art veterinary intravenous (IV) delivery mechanisms, and intelligent veterinary intravenous (IV) systems.
Get your veterinary intravenous (iv) solutions market report here!
What are the leading drivers of growth in the veterinary intravenous (iv) solutions market?
Expectations are that the rise in incidence of various animal disorders may trigger an upswing in the veterinary intravenous solutions sector. Such animal ailments that compromise their vitality and wellness include anthrax, leptospirosis, rabies, canine distemper, heartworm disease among others. Factors such as intensive farming techniques, wildlife intrusion, and antibiotic resistance are contributing to this proliferation. Veterinary IV solutions play a crucial role in rehydrating animals suffering from diseases that lead to dehydration like gastroenteritis or severe infections, thereby boosting overall health performance. AVMA Publications, a division of the American Veterinary Medical Association, cited a significant rise in domestic animal rabies cases in July 2024, with figures standing at 345 cases in 2022, up by 10.9% from the previous year’s 311 cases. This serves to emphasize the critical driver role played by increasing animal disease prevalence in escalating the veterinary intravenous solution market’s growth. The veterinary intravenous solutions market is expected to further thrive with rising expenditure on animal health commodities. These are drugs, supplements, and therapies crafted to enhance or maintain an animal’s state of health. Factors driving the upswing in expenditure on these products include increasing pet ownership, heightened consciousness of animal health, veterinary care technological progress, and the quest for superior disease prevention and intervention methods. Moreover, veterinary IV solutions actively contribute to escalated animal health product expenditure by answering to pressing healthcare needs and propelling veterinary care improvements. An illustrative case is the 6.9% growth in the veterinary medicinal products market in 2023, per data from the Republic of Estonia Agency of Medicines, a regulatory agency based in Estonia. The market value was pegged at $20.54 million, a marked increase from $19.21 million, the previous year’s value. Thus, the rise in expenditure on animal health products is a major driver for the growth of the veterinary intravenous solutions market.
What are the key segments defining the veterinary intravenous (iv) solutions market?
The veterinary intravenous (IV) solutions market covered in this report is segmented –
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition
2) By Animal Type: Companion Animals, Production Animals
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users
Subsegments:
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer’s Solution, Dextrose in Water (D5W), Ringer’s Solution, Balanced Electrolyte Solutions
2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)
3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins
4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20686&type=smp
Who are the key players steering the development of the veterinary intravenous (iv) solutions market?
Major companies operating in the veterinary intravenous (IV) solutions market are Merck & Co. Inc., Baxter International Inc., Zoetis Inc., Fresenius Kabi AG, Elanco Animal Health Incorporated, B. Braun Melsungen AG, Virbac SA, Dechra Pharmaceuticals PLC, Vetoquinol SA, Norbrook Laboratories Limited, Ceva Santé Animale, Revival Animal Health Inc., Aromor Animal Health, Jorgensen Laboratories LLC, Pharmacosmos AS, Sykes Veterinary International Pty Ltd., Rusoma Laboratories Private Limited, Patterson Companies Inc., NexGen Veterinary, Soxa Formulations & Research Pvt. Ltd
What emerging trends are influencing the growth of the veterinary intravenous (iv) solutions market?
Leading firms in the veterinary intravenous (IV) solutions market are prioritizing the development of enhanced products like fluoroquinolones to bolster effectiveness and safety. Fluoroquinolones are potent antibiotics used in human and veterinary medicine to manage different bacterial infections, with careful administration to lessen the risk of resistance and side effects. In April 2024, for instance, Elanco, an American pharmaceutical company, introduced Pradalex, a pradofloxacin solution injected and approved by the US Food and Drug Administration (FDA), a US health body. The swine approval caters to the treatment of swine respiratory disease (SRD) linked with bordetella bronchiseptica, Glaesserella (Haemophilus) parasuis, Pasteurella multocida, streptococcus suis, and mycoplasma hyopneumoniae. Pradalex, a 3rd generation fluoroquinolone, is considered an extremely important antimicrobial. The packaging of the drug emphasizes that it should only be used if other non-fluoroquinolone treatments have been considered.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20686
Which regions are most influential in expanding the veterinary intravenous (iv) solutions market?
North America was the largest region in the veterinary intravenous (IV) solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the veterinary intravenous (IV) solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Similar Reports By The Business Research Company:
Veterinary Biologics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-biologics-global-market-report
Veterinary Hematology Analyzers Global Market Report 2025
Veterinary Telehealth Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/veterinary-telehealth-market
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
